Deciphering the History of ERK Activity from Fixed-Cell Immunofluorescence Measurements

Abhineet Ram,Michael Pargett,Yongin Choi,Devan Murphy,Markhus Cabel,Nont Kosaisawe,Gerald Quon,John Albeck

DOI: https://doi.org/10.1101/2024.02.16.580760

2024-02-17

Abstract:The Ras/ERK pathway drives cell proliferation and other oncogenic behaviors, and quantifying its activity is of high interest in cancer diagnosis and therapy. Pathway activation is often assayed by measuring phosphorylated ERK. However, this form of measurement overlooks dynamic aspects of signaling that can only be observed over time. In this study, we combine a live, single-cell ERK biosensor approach with multiplexed immunofluorescence staining of downstream target proteins to ask how well immunostaining captures the dynamic history of ERK activity. Combining linear regression, machine learning, and differential equation models, we develop an interpretive framework for immunostains, in which Fra-1 and pRb levels imply long term activation of ERK signaling, while Egr-1 and c-Myc indicate recent activation. We show that this framework can distinguish different classes of ERK dynamics within a heterogeneous population, providing a tool for annotating ERK dynamics within fixed tissues.

Molecular Biology

What problem does this paper attempt to address?

This paper aims to solve the long - standing problem of how to decode ERK activity from fixed - cell immunofluorescence measurements. Specifically, the study attempts to evaluate to what extent immunostaining can capture the kinetic history of ERK activity by combining live - cell ERK biosensor methods with multiplex immunofluorescence staining of downstream target proteins. Through linear regression, machine learning, and differential equation models, the paper has developed an interpretive framework in which Fra - 1 and pRb levels imply long - term activation of ERK signaling, while Egr - 1 and c - Myc indicate recent activation. This framework can distinguish different ERK kinetic categories in heterogeneous populations and provides a tool for annotating ERK kinetics within fixed tissues.

### Research Background
- **Ras/ERK Pathway**: It regulates various cell behaviors and tissue homeostasis, and its terminal kinase ERK is crucial for decisions such as cell - cycle entry, migration, or differentiation.
- **Clinical Importance of ERK Activity**: The quantitative intensity and timing of ERK activity play a key role in disease progression and treatment. For example, the fate of individual cells can be altered by a slight disruption of ERK activity, and residual ERK activity affects the efficacy of targeted kinase inhibitor therapy.
- **Limitations of Current Measurement Methods**: The method of using antibodies to detect phosphorylated ERK has limited spatio - temporal resolution and quantitative accuracy and cannot reliably reflect the long - term activation history of ERK.

### Research Objectives
- **Develop a New Method**: Explore the feasibility of using antibody measurements of downstream target genes (ETGs) to estimate past ERK activity.
- **Establish an Interpretive Framework**: Develop an interpretive framework that can infer the history of ERK activity from fixed - cell data by combining live - cell ERK biosensors and multiplex immunofluorescence staining.
- **Verify the Effectiveness of the Method**: Predict ERK activity characteristics through statistical models and machine learning and verify the different memory spans of different gene products reporting ERK history.

### Main Findings
- **Fra - 1 and pRb**: Best predict the long - term average activity of ERK.
- **Egr - 1 and c - Myc**: Best predict the short - term recent activation of ERK.
- **Model Performance**: Convolutional neural networks (CNN) perform best in predicting most ERK targets, especially Egr - 1 and pRb, showing a significant nonlinear response.
- **Classification Model**: Through decision - tree classifiers, cells are successfully classified into different ERK activity categories, further validating gene expression characteristics under different ERK kinetic patterns.

### Conclusion
This study demonstrates the potential to infer the history of ERK activity through fixed - cell immunofluorescence measurements, providing a new tool for ERK kinetic analysis in tumor tissues. These findings contribute to a more accurate assessment of the role of ERK signaling in diseases and support cancer diagnosis and treatment.